Imprivata Enterprise Access Management now offers facial recognition, AI-powered behavioral analytics, and high-assurance identity verification to further streamline clinical access, improve operational efficiency, and strengthen security posture March 16, 2026 18:00 ET  | Source: Imprivata MELBOURNE, March 16, 2026 (GLOBE NEWSWIRE) — Imprivata, a leading provider of access management solutions for healthcare and other mission-critical industries, today introduced […]

March 13, 2026 09:54 ET  | Source: Junshi Biosciences SHANGHAI, March 13, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2025 and provided corporate updates. FINANCIAL

UK marks first international launch of the HYDROS Robotic System, with additional international expansion planned in 2026 March 12, 2026 09:00 ET  | Source: PROCEPT BioRobotics SAN JOSE, Calif., March 12, 2026 (GLOBE NEWSWIRE) — PROCEPT BioRobotics (Nasdaq: PRCT), today announced the international expansion of the HYDROS Robotic System, the company’s next-generation platform for delivering Aquablation therapy

March 12, 2026 04:04 ET  | Source: SK pharmteco Inc. RANCHO CORDOVA, Calif., March 12, 2026 (GLOBE NEWSWIRE) — SK pharmteco today announced the successful CGMP qualification of its manufacturing facility in Corbeil-Essonnes, France. This state-of-the-art plant is now fully operational and prepared to support late-stage and commercial viral vector programs at scale. Recently, the facility was inspected by

March 11, 2026 11:10 ET  | Source: Io Therapeutics, Inc. SPRING, Texas, March 11, 2026 (GLOBE NEWSWIRE) — Io Therapeutics, Inc. in Spring, Texas, announces collaborative publication of data from preclinical studies with scientists at The University of Texas MD Anderson Cancer Center demonstrating effectiveness of the retinoid X receptor (RXR) agonist compound IRX4204 in models of

March 11, 2026 11:00 ET  | Source: Royal Philips March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare

March 11, 2026 09:32 ET  | Source: TekniPlex Wayne, PA, March 11, 2026 (GLOBE NEWSWIRE) — TekniPlex Healthcare, a global leader in advanced materials science and precision manufacturing for the medical and healthcare industries, announced its participation at the China International Medical Equipment Fair (CMEF) 2026. TekniPlex will highlight its global capabilities in medical materials and precision

March 10, 2026 11:00 ET  | Source: Royal Philips March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and

March 10, 2026 09:00 ET  | Source: Egg Medical, Inc. WASHINGTON, March 10, 2026 (GLOBE NEWSWIRE) — Egg Medical, a leader in enhanced radiation protection devices (ERPD), today announced the results of a Late-Breaking Trial presented at the Cardiovascular Research Technologies (CRT) 2026 conference. The study, presented by Santiago Garcia, MD, of The Christ Hospital, confirms that

March 09, 2026 10:18 ET  | Source: Menarini FLORENCE, Italy, March 09, 2026 (GLOBE NEWSWIRE) — 2025 was a “positive year” for Menarini, which is celebrating its 140th anniversary this year, despite considerable global “turbulence”. Lucia Aleotti, shareholder and member of the Menarini Board, said so with a smile as she opened the company’s customary annual meeting

March 09, 2026 09:00 ET  | Source: Junshi Biosciences SHANGHAI, March 09, 2026 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug applications (the “NDAs”) for the company’s product, toripalimab injection (subcutaneous

March 09, 2026 07:00 ET  | Source: Rapport Therapeutics, Inc. Partnership leverages Tenacia’s expertise in central nervous system (CNS) drug development and commercialization to accelerate U.S. and global development of RAP-219 Tenacia obtains exclusive rights to develop and commercialize RAP-219 in Greater China across indications, including focal onset seizures and bipolar mania Rapport to receive upfront cash

March 08, 2026 14:00 ET  | Source: Coalition of Asia Pacific Tobacco Harm Reduction Advocates WELLINGTON, New Zealand, March 09, 2026 (GLOBE NEWSWIRE) — The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) says the rise of etomidate-laced “zombie vapes” in parts of Asia is a serious criminal and public health problem, but warns governments not

March 06, 2026 03:00 ET  | Source: Claritas HealthTech Ltd LONDON and SYDNEY, March 06, 2026 (GLOBE NEWSWIRE) — Claritas NucMed Technologies Ltd (Claritas), a healthcare technology company specializing in state-of-the-art image enhancement, noise reduction, segmentation and quantification, and related AI technologies, is pleased to announce that the Australian regulatory agency for medicines and medical devices, namely, the Therapeutic

March 05, 2026 13:30 ET  | Source: Esaote VIENNA, Austria, March 05, 2026 (GLOBE NEWSWIRE) — Easy to transport, featuring compact size and high-quality images, developed to revolutionise and facilitate the work of interventional radiologists all around the world. This is MyLabTM E85 GTS, the new cart-based ultrasound system that Esaote, a leading Italian company in medical imaging innovation,